|
False Claims Act Update & Alert |
||||||
|
Taxpayers
Against Fraud Education Fund | Washington, D.C. |
WWW.TAF.ORG |
||||||
| |
n
Previous
Newsletters
|
|||||
 Bristol-Myers
Squibb to Pay $499 Million for Pricing and MarketingBristol-Myers Squibb has entered into an "agreement in principle" with the U.S. Department of Justice for $499 million to settle federal investigations into drug pricing and marketing practices surrounding its products. The company did not announce the name of the drugs in question, but the settlement on civil and criminal charges is believed to cover a False Claims Act case. >> To read more |
||||||
 IRS Whistleblower Act
Signed
President Bush has signed into law an IRS whistleblower
act which would reward whistleblowers with 15%
to 30% of the amount collected.
"It's a shame that an
agency that could really benefit from whistle-blowers
hasn't encouraged them, but I hope that will change with
the new law," said Sen. Charles Grassley (R-IA)
sponsor of the law. >>
To read more |
||||||
 FL
Hospital to Pay $14.25 MillionJackson Memorial Health System, which owns the 1,776-bed Jackson Memorial Hospital in Miami, has agreed to pay $14.25 million to settle Medicare cost reporting fraud allegations. The settlement is connected to a raft of ongoing investigations associated with more than 20 hospitals that has already pulled in about $50 million in settlements. >> To read more |
||||||
 Chandler Settles for $5 MillionA lawsuit brought in 1997 by former Cook County, Illinois project director Janet Chandler has been settled for $5 million. The case went to the Supreme Court in 2003 over whether individuals could sue local governments under the False Claims Act. The court ruled unanimously that they could. TAF filed an amicus brief in support of Chandler. >> To read more |
||||||
 Mucho
Problemo at LillyThe New York Times reports that Eli Lilly created a marketing program called "Viva Zyprexa," in which the company aggressively off-label marketed Zyprexa to elderly patients suffering from dementia. Zyprexa, which had $4.2 billion in sales in 2005, is meant only for schizophrenia and bipolar disorders. >> To read more |
||||||
 Fox
in the Chicken House?
The Department of Interior has appointed David Deal head of a new advisory panel to review complaints about the Mineral Management Service's corruption and mismanagement which has resulted in billions of dollars being lost or stolen from the U.S. Treasury. From 1975 to 2003, Mr. Deal served as an attorney for the American Petroleum Institute. Mr. Deal's appointment gives the appearance of a conflict, which will surely make Mr. Deal's job more difficult. >> To read more |
||||||
